Cosciens shares plummet after growth hormone test flops in Phase III trial

Cosciens Biopharma, formerly known as Aeterna Zentaris, has published top-line results from the Phase III DETECT study of its growth hormone stimulation test macimorelin, showing that the study did not meet its primary endpoint. The Canadian company has evaluated its…